A recent study by Fuchs et al. found that the levels of plasma DNA were normalized in clinical remission, whereas MPO tended to normalize but remained slightly above control values, indicating that DNA and MPO might reflect the disease activity in TTP patients [11]. The gene discussed is MPO; the disease is thrombotic thrombocytopenic purpura.